套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-009917 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-22-046719 Act: 34 Size: 519 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-007038 Size: 6 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-007042 Size: 6 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-22-007037 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-006543 Size: 9 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-006544 Size: 9 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-006545 Size: 9 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-006546 Size: 9 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-006547 Size: 10 KB 网页链接